SZSE Ticker: 300143

Inkon Life Technology Co., Ltd.

盈康生命科技股份有限公司

盈康生命

INKON LIFE

Listing Date: 2010-12-09

Board: GEM

Industry Classification: Public Health

Stock Sea Navigation May 17 Shanghai and Shenzhen Stock Market Announcement Prompt Stock Sea Navigation_Sina Finance_Sina.com

Stock Sea Navigation May 17 Shanghai and Shenzhen Stock Market Announcement Prompt Stock Sea Navigation_Sina Finance_Sina.com

Highlights of the announcement on the evening of May 16: Qianjin Pharmaceutical clarifies that the company does not have the production and sales of Qianjin

Reply from Haier Bio's Board Secretary: Nucleic acid sampling workstation business is advancing steadily_Stock News_Market Gold Online

Listed company evening announcement express on May 16_Sina Finance_Sina.com

During the month, 23 important shareholders of listed companies announced to increase their holdings of their own shares.

Yingkang Life was increased, and the actual controller and persons acting in concert held 40.66% of the shares. Jiemian News

The concerted action of the actual controller of Yingkang Life completed the increase of 5,239,600 shares at a cost of 59,999,100 yuan_Finance Net

Grasping the Opportunities of the Digital Economy Era, Rebuilding the Competitive Advantage of Ecological Brands

17 stocks with buy rating latest: Paine Technology CFi.CN Zhongcai Network

8 stocks with buy rating latest: Yingkang Life-CFi.CN Zhongcai Network

What are the skin and beauty concept stocks in 2022? List and ranking of leading stocks in skin and beauty (stock code)

4 shares with buy rating latest: Focus Media CFi.CN Zhongcai Network

Summary of the 2021 annual report and 2022 first quarter report of the medical sector of Sinolink Securities: The overall performance is clear, and it still maintains a strong growth ability! -Funds Financial Sector

The boom is still high! The 2021 annual report of CSI Medical ended perfectly, and the performance of the top ten stocks increased by 48%! 1st Quarterly Report Gao Liang Continues-Funds-Finance

The boom is still high! The 2021 annual report of CSI Medical ended perfectly, and the performance of the top ten stocks increased by 48%! The first quarterly report Gao Liang continues-

Yingkang Life: Net profit in 2021 is about -364 million yuan per net

Yingkang Life released a performance forecast: the revenue is expected to exceed 1 billion for the first time, creating a one-stop platform for tumor pre-diagnosis and treatment Economic Review Rongyi Information Network

Yingkang Life released the 2021 performance forecast: after asset optimization, the revenue exceeded 1 billion for the first time, and the pace of development was more solid and stable. Economic Review Rongyi Information Network

Yingkang Life released a performance forecast: It is expected that the revenue will exceed 1 billion for the first time, and it will create a one-stop platform for tumor pre-diagnosis and treatment-

Yingkang Life released the 2021 performance forecast: after asset optimization, the revenue exceeded 1 billion for the first time, and the development pace was more solid and stable-

Want to see more data? Registered subscribers can see all the data.